Chemotherapy and Targeted Therapy

Merck’s ADC Strategy Gains Momentum: Positive Clinical Data Bolsters Sac-TMT as a Future Cancer Standard mercks-adc-strategy-gains-momentum-positive-clinical-data-bolsters-sac-tmt-as-a-future-cancer-standard

Merck’s ADC Strategy Gains Momentum: Positive Clinical Data Bolsters Sac-TMT as a Future Cancer Standard

Ammar Sabilarrohman July 15, 2026

In the high-stakes world of oncology research, Merck & Co. has reached a pivotal juncture in its...

From Diabetes to MASH: How the GLP-1 Revolution is Redefining the Biobanking Landscape from-diabetes-to-mash-how-the-glp-1-revolution-is-redefining-the-biobanking-landscape-1

From Diabetes to MASH: How the GLP-1 Revolution is Redefining the Biobanking Landscape

Nana July 15, 2026

The pharmaceutical landscape has been fundamentally reshaped by the meteoric rise of GLP-1 receptor agonists. What began...

Draig Therapeutics Secures $65M Series B to Advance "Best-in-Disease" Psychiatric Pipeline draig-therapeutics-secures-65m-series-b-to-advance-best-in-disease-psychiatric-pipeline

Draig Therapeutics Secures $65M Series B to Advance "Best-in-Disease" Psychiatric Pipeline

Jia Lissa July 15, 2026

By Delilah Alvarado Published July 14, 2026 In a significant vote of confidence for the resurgence of...

Moderna’s Second Act: Betting on In Vivo CAR-T, Oncology, and the ‘Lucy’ AI Engine modernas-second-act-betting-on-in-vivo-car-t-oncology-and-the-lucy-ai-engine

Moderna’s Second Act: Betting on In Vivo CAR-T, Oncology, and the ‘Lucy’ AI Engine

Dwi Wanna July 15, 2026

Moderna, the biotechnology giant that became a household name through its rapid development of mRNA-based COVID-19 vaccines,...

Convergence at the Crescent City: AAPS PharmSci 360 2026 Set to Define the Future of Drug Development convergence-at-the-crescent-city-aaps-pharmsci-360-2026-set-to-define-the-future-of-drug-development

Convergence at the Crescent City: AAPS PharmSci 360 2026 Set to Define the Future of Drug Development

Lina Irawan July 14, 2026

The pharmaceutical landscape is currently undergoing a paradigm shift driven by the rapid integration of artificial intelligence,...

The New Economics of Medicine: How Most-Favored-Nation Pricing is Reshaping Generic Drug Strategy the-new-economics-of-medicine-how-most-favored-nation-pricing-is-reshaping-generic-drug-strategy

The New Economics of Medicine: How Most-Favored-Nation Pricing is Reshaping Generic Drug Strategy

Ali Ikhwan July 14, 2026

The pharmaceutical landscape in the United States is undergoing a profound structural transformation. As policymakers intensify their...

The Future of Colorectal Cancer Screening: Freenome and Abbott’s High-Stakes Path to Market Dominance the-future-of-colorectal-cancer-screening-freenome-and-abbotts-high-stakes-path-to-market-dominance

The Future of Colorectal Cancer Screening: Freenome and Abbott’s High-Stakes Path to Market Dominance

Sagoh July 13, 2026

The landscape of colorectal cancer (CRC) screening is undergoing a seismic shift. As the medical community pushes...

Evolution in B2B Media: WTWH Media Rebrands as Arrowfly to Reflect Expanded Market Presence evolution-in-b2b-media-wtwh-media-rebrands-as-arrowfly-to-reflect-expanded-market-presence

Evolution in B2B Media: WTWH Media Rebrands as Arrowfly to Reflect Expanded Market Presence

Ammar Sabilarrohman July 13, 2026

CLEVELAND, OH — In a move signaling both a maturation of its corporate identity and a bold...

The Agentic Arms Race: Salesforce and Veeva Battle for the Future of Life Sciences AI the-agentic-arms-race-salesforce-and-veeva-battle-for-the-future-of-life-sciences-ai

The Agentic Arms Race: Salesforce and Veeva Battle for the Future of Life Sciences AI

Lina Irawan July 13, 2026

The pharmaceutical and life sciences industry is undergoing a tectonic shift, moving from static digital transformation to...

Beyond the Burn: Rubedo’s Breakthrough in Senescence-Targeting Dermatology beyond-the-burn-rubedos-breakthrough-in-senescence-targeting-dermatology

Beyond the Burn: Rubedo’s Breakthrough in Senescence-Targeting Dermatology

Neng Nana July 13, 2026

For millions of individuals living with actinic keratoses (AK)—the rough, scaly, and potentially pre-cancerous patches of skin...

Chemotherapy and Targeted Therapy

Merck’s ADC Strategy Gains Momentum: Positive Clinical Data Bolsters Sac-TMT as a Future Cancer Standard

From Diabetes to MASH: How the GLP-1 Revolution is Redefining the Biobanking Landscape

Draig Therapeutics Secures $65M Series B to Advance "Best-in-Disease" Psychiatric Pipeline

Moderna’s Second Act: Betting on In Vivo CAR-T, Oncology, and the ‘Lucy’ AI Engine

Convergence at the Crescent City: AAPS PharmSci 360 2026 Set to Define the Future of Drug Development

The New Economics of Medicine: How Most-Favored-Nation Pricing is Reshaping Generic Drug Strategy

The Future of Colorectal Cancer Screening: Freenome and Abbott’s High-Stakes Path to Market Dominance

Evolution in B2B Media: WTWH Media Rebrands as Arrowfly to Reflect Expanded Market Presence

The Agentic Arms Race: Salesforce and Veeva Battle for the Future of Life Sciences AI

Beyond the Burn: Rubedo’s Breakthrough in Senescence-Targeting Dermatology

You may have missed

Mastering the Gravity-Defying Flow: The Art of the Ashtanga Jump-Back

Cultivating Prosperity: The BRIDGES Engine and the Future of Rural Agriculture

A Lifesaving Breakthrough for BRCA Carriers: Cambridge Study Confirms Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk

The Pan-Viral Frontier: Can Cocrystal Pharma Rewrite the Rules of Antiviral Development?